Netherlands· NL-4c7fab61904d
Dexamethason Tramedico zonder conserveermiddel 1 mg/ml oogdruppels, oplossing
A dexamethasone product containing dexamethasondinatriumfosfaat, registered in Netherlands by Tramedico B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Dexamethasone is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BA01 (dexamethasone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Dexamethasone · ATC S01BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamethasone costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamethasone · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$362.24
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DEXAMETHASONDINATRIUMFOSFAAT
- Manufacturer
- Tramedico B.V.
- Country
- Netherlands (NL)
- ATC code
- S01BA01
- ATC class
- Dexamethasone
- Defined daily dose
- 0.2 mg, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id130651
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
96 interactions on record for dexamethasone.
Graded by severity as the source publishes them — 41 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamethasone · interactions on record
96 records
- 41 moderate
- 55 minor
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexamethasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDarazurPharmaselect International Beteiligungs GmbH
- SwedenAxiumopto 1 mg/ml Ögondroppar, lösning i endosbehållareUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- FranceAFLAVIS 1 mg/mL, collyre en solutionLABORATOIRES DOLIAGE DEVELOPPEMENT
- SwitzerlandDexocol 1 mg/ml, collyre en solutionHorus Pharma Suisse SA
- IrelandDexafree 1 mg/ml eye drops, solution in single dose containerIMED Healthcare Ltd.
- NorwayMonopexLaboratoires Théa S.A.S
- IcelandOpnolKaro Pharma AB*
- FinlandIsopto-MaxidexAlcon Couvreur N.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexamethason Hcs, Dexamethason Kalceks
- Belgium · Darazon, Dexalis
- Bulgaria · Dexanova, Дeксаметазон Крка
- Cyprus · Axium-Opto, Decadron
- Czechia · Dexamed, Dexamethasone Fmk
- Germany · Dexa, Dexa Edo
- Denmark · Axiumopto, Dexacur
- Estonia · Caltrixan, Dexamethason Krka
- Spain · Amexxine, Dexafree
- Finland · Axiumopto, Dexacur
- France · Aflavis, Dectancyl
- United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
- Greece · Amelinor, Axium
- Croatia · Darazur, Deksametazon Kalceks
- Hungary · Darazur, Dexamethasone Kalceks
- Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
- Iceland · Dexametason Abcur, Dexamethason Krka
- Italy · Amexzur, Cortmuper
- Liechtenstein · Neofordex, Ozurdex
- Lithuania · Dexamethason Krka, Dexamethasone Kalceks
- Luxembourg · Dexalis, Dexamethasone Kalceks
- Latvia · Dexamethason Krka, Dexamethasone Kalceks
- Malta · Axium-Opto, Decadron
- Norway · Dexacur, Dexametason Abcur
- Poland · Covexan, Darazur
- Portugal · Amexzur, Decadron
- Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
- Sweden · Axiumopto, Baxil
- Slovenia · Deksametazon Krka, Deksametazon Medochemie
- Slovakia · Amexxine, Dexametazón Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2453993-c3ad-4838-9e22-a381355ab8ad GET /v1/drugs/f2453993-c3ad-4838-9e22-a381355ab8ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130651_smpc.pdf",
"strength": null,
"atc_label": "Dexamethasone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130651",
"excipients": [
"DINATRIUMEDETAAT 2-WATER",
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"NATRIUMCHLORIDE",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"DEXAMETHASONDINATRIUMFOSFAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130651.pdf",
"authorised_at": "2023/02/22",
"procedure_number": "PT/H/2365/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "130651",
"additional_monitoring": "N"
}See everything about dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.